Literature DB >> 29016349

Structural mechanisms of HECT-type ubiquitin ligases.

Sonja Lorenz1.   

Abstract

Ubiquitin ligases (E3 enzymes) transfer ubiquitin from ubiquitin-conjugating (E2) enzymes to target proteins. By determining the selection of target proteins, modification sites on those target proteins, and the types of ubiquitin modifications that are formed, E3 enzymes are key specificity factors in ubiquitin signaling. Here, I summarize our knowledge of the structural mechanisms in the HECT E3 subfamily, many members of which play important roles in human disease. I discuss interactions of the conserved HECT domain with E2 enzymes, ubiquitin and target proteins, as well as macromolecular interactions with regulatory functions. While we understand individual steps in the catalytic cycle of HECT E3 enzymes on a structural level, this review also highlights key aspects that have yet to be elucidated. For instance, it remains unclear how diverse target proteins are presented to the catalytic center and how certain HECT E3 enzymes achieve specificity in ubiquitin linkage formation. The structural and functional properties of the N-terminal regions of HECT E3 enzymes that likely act as signaling hubs are also largely unknown. Structural insights into these aspects may open up routes for a therapeutic intervention with specific HECT E3 functions in distinct pathophysiological settings.

Entities:  

Keywords:  E3 enzyme; X-ray crystallography; enzyme mechanism; enzyme regulation; posttranslational modification

Mesh:

Substances:

Year:  2018        PMID: 29016349     DOI: 10.1515/hsz-2017-0184

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  43 in total

1.  WW domain-mediated regulation and activation of E3 ubiquitin ligase Suppressor of Deltex.

Authors:  Weiyi Yao; Zelin Shan; Aihong Gu; Minjie Fu; Zhifeng Shi; Wenyu Wen
Journal:  J Biol Chem       Date:  2018-09-13       Impact factor: 5.157

Review 2.  ITCH as a potential therapeutic target in human cancers.

Authors:  Qing Yin; Clayton J Wyatt; Tao Han; Keiran S M Smalley; Lixin Wan
Journal:  Semin Cancer Biol       Date:  2020-03-10       Impact factor: 15.707

Review 3.  Structural basis of generic versus specific E2-RING E3 interactions in protein ubiquitination.

Authors:  Mehmet Gundogdu; Helen Walden
Journal:  Protein Sci       Date:  2019-08-23       Impact factor: 6.725

Review 4.  The structure and regulation of the E3 ubiquitin ligase HUWE1 and its biological functions in cancer.

Authors:  Xiaofeng Gong; Danyu Du; Yanran Deng; Yuqi Zhou; Li Sun; Shengtao Yuan
Journal:  Invest New Drugs       Date:  2020-02-01       Impact factor: 3.850

5.  Comparative analysis of the catalytic regulation of NEDD4-1 and WWP2 ubiquitin ligases.

Authors:  Hanjie Jiang; Stefani N Thomas; Zan Chen; Claire Y Chiang; Philip A Cole
Journal:  J Biol Chem       Date:  2019-10-02       Impact factor: 5.157

Review 6.  The role of E3 ubiquitin ligase HECTD3 in cancer and beyond.

Authors:  Qiuyun Jiang; Fubing Li; Zhuo Cheng; Yanjie Kong; Ceshi Chen
Journal:  Cell Mol Life Sci       Date:  2019-10-21       Impact factor: 9.261

7.  Protein engineering of a ubiquitin-variant inhibitor of APC/C identifies a cryptic K48 ubiquitin chain binding site.

Authors:  Edmond R Watson; Christy R R Grace; Wei Zhang; Darcie J Miller; Iain F Davidson; J Rajan Prabu; Shanshan Yu; Derek L Bolhuis; Elizaveta T Kulko; Ronnald Vollrath; David Haselbach; Holger Stark; Jan-Michael Peters; Nicholas G Brown; Sachdev S Sidhu; Brenda A Schulman
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-26       Impact factor: 11.205

8.  Oligomerization of the HECT ubiquitin ligase NEDD4-2/NEDD4L is essential for polyubiquitin chain assembly.

Authors:  Dustin R Todaro; Allison C Augustus-Wallace; Jennifer M Klein; Arthur L Haas
Journal:  J Biol Chem       Date:  2018-10-04       Impact factor: 5.157

Review 9.  HECT E3 ubiquitin ligases - emerging insights into their biological roles and disease relevance.

Authors:  Yaya Wang; Diana Argiles-Castillo; Emma I Kane; Anning Zhou; Donald E Spratt
Journal:  J Cell Sci       Date:  2020-04-07       Impact factor: 5.285

10.  Loss of nuclear UBE3A activity is the predominant cause of Angelman syndrome in individuals carrying UBE3A missense mutations.

Authors:  Stijn N V Bossuyt; A Mattijs Punt; Ilona J de Graaf; Janny van den Burg; Mark G Williams; Helen Heussler; Ype Elgersma; Ben Distel
Journal:  Hum Mol Genet       Date:  2021-04-30       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.